Discover our latest insights. 

Alzheimer’s disease affects more than 6 million Americans and is the leading cause of dementia, but it can be challenging to correctly diagnose. Results of a new study suggest that a simple blood test may be able to quickly and accurately improve Alzheimer’s diagnosis. Private Health Management (PHM) is committed to providing our clients with Alzheimer’s with the most advanced care and we have helped them receive this useful test. Explore key takeaways from this promising study.

Each June, over 40,000 oncology professionals, including physicians, researchers, patient advocates, and pharmaceutical representatives attend the American Society of Clinical Oncology (ASCO) meeting in Chicago, IL. This meeting is considered the premiere forum for the presentation of the most recent scientific progress made in cancer research. Private Heath Management’s research scientists attend dozens of presentations each year to stay current on the latest clinical data and emerging technologies. Here are some of the most exciting developments from ASCO 2024.

On July 29, the U.S. Food and Drug Administration (FDA) approved Guardant Health’s Shield™ test, the first colorectal cancer screening test that analyzes a blood sample to identify molecular signs of cancer. The latest research shows that early detection of cancer improves treatment outcomes and survival rates and experts predict that having a non-invasive option will help to screen more patients and catch colorectal cancer at treatable stages.

During the warm months of spring and summer, the looming threat of ticks becomes more palpable. While most people are aware of Lyme disease as the primary concern, ticks carry a staggering array of 13 other diseases.

Alzheimer’s disease, the most common form of dementia in the United States, affects millions of Americans, predominately striking after the age of 60. However, there is a lesser-known rare variant of Alzheimer’s called Posterior Cortical Atrophy (PCA) that makes up about 5% of cases.

For the first time, the FDA has approved a treatment to reduce the severity of dangerous allergic reactions due to accidental exposure to food allergens. Here’s what to know about this new tool to help manage food allergies.